Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Adel Mahjoub"'
Autor:
Erik Freeland DO, Aine Gallahue BS, Adel Mahjoub MD, Pietro M. Gentile BS, Nicholas D'Antonio MD, Vineeth Romiyo BS
Publikováno v:
Foot & Ankle Orthopaedics, Vol 9 (2024)
Introduction/Purpose: Tantalum coated metal spacers (TCMS) have recently been utilized to fill and provide structure to large bony defects in the hindfoot. Tantalum is an appealing material due to its biocompatibility, lack of immune response generat
Externí odkaz:
https://doaj.org/article/c46b4142d62f491daf8d5b66897b2dfa
Publikováno v:
Foot & Ankle Orthopaedics, Vol 8 (2023)
Category: Ankle Arthritis; Ankle Introduction/Purpose: Tantalum coated metal spacers (TCMS) have recently been utilized to fill and provide structure to large bony defects in the hindfoot. TCMS have a porous structure and elastic modulus similar to c
Externí odkaz:
https://doaj.org/article/38c71e0bcd264d549ef8bffc8fe46d26
Publikováno v:
Foot & Ankle Orthopaedics, Vol 8 (2023)
Category: Ankle Arthritis Introduction/Purpose: Total ankle replacement has risen in popularity as the contemporary treatment-of-choice for end-stage ankle osteoarthritis. INFINITY™ Total Ankle System (Stryker, Kalamazoo, MI) is one of the most fre
Externí odkaz:
https://doaj.org/article/f752a8385b8b4915afdc77e43f79c9a2
Publikováno v:
Sarcoma, Vol 2015 (2015)
Aldehyde dehydrogenase (ALDH) is a cancer stem cell marker. Retinoic acid has antitumor properties, including the induction of apoptosis and inhibition of proliferation. Retinal, the precursor of retinoic acid, can be oxidized to retinoic acid by deh
Externí odkaz:
https://doaj.org/article/1bce8e86b20a46e780e2fcca07f1b1b0
Publikováno v:
JBJS Case Connector. 12
A 33-year-old man who had experienced polytraumatic injury from a motorcycle collision 5 months previously presented to the clinic with right ankle pain. On physical examination, anterior ankle tenderness was present, and imaging revealed a previousl
Publikováno v:
JBJS Case Connector. 11
Cases Long-bone fractures in patients with Klippel-Trenaunay syndrome (KTS), a rare disorder of the venous, lymphatic, and capillary system, are difficult to treat with many complications. Two patients diagnosed with KTS presented with closed femoral
Autor:
Alejandro Morales-Restrepo, Kavita Ramnath, Jared A. Crasto, Kurt R. Weiss, Rebecca J. Watters, Jessica C. Tebbets, Jonathan B. Mandell, Adel Mahjoub, Mitchell S. Fourman
Publikováno v:
Oncotarget
// Jared Anthony Crasto 1, * , Mitchell Stephen Fourman 1, * , Alejandro Morales-Restrepo 1 , Adel Mahjoub 1, 2 , Jonathan Brendan Mandell 1 , Kavita Ramnath 1, 3 , Jessica C. Tebbets 1 , Rebecca J. Watters 1, 4 and Kurt Richard Weiss 1, 5 1 Musculos
Autor:
Shibing Yu, Jessica C. Tebbets, Mitchell S. Fourman, Jon B. Mandell, Kurt R. Weiss, Peter E. Alexander, Adel Mahjoub, Jared A. Crasto
Publikováno v:
Clinical Orthopaedics & Related Research. 476:479-487
BackgroundCurrent preclinical osteosarcoma (OS) models largely focus on quantifying primary tumor burden. However, most fatalities from OS are caused by metastatic disease. The quantification of metastatic OS currently relies on CT, which is limited
Autor:
Kurt R. Weiss, Margaret L. Hankins, Lu Feiqi, Alejandro Morales-Restrepo, Adel Mahjoub, Mitchell S. Fourman, Jonathan B. Mandell, Rebecca J. Watters
Publikováno v:
Annals of Surgical Oncology
Background Surgical resection with negative margins is the foundation of extremity sarcoma management. Failure to achieve negative surgical margins can result in local recurrence (LR), a potentially devastating complication. Indocyanine green (ICG) i
Autor:
Adel Mahjoub, Jonathan B. Mandell, Rashmi Agarwal, Jared A. Crasto, Mitchell S. Fourman, Kurt R. Weiss
Publikováno v:
Osteosarcoma-Biology, Behavior and Mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::554f3e07a36705671dccef65d704ae66
http://www.intechopen.com/articles/show/title/the-use-of-molecular-pathway-inhibitors-in-the-treatment-of-osteosarcoma
http://www.intechopen.com/articles/show/title/the-use-of-molecular-pathway-inhibitors-in-the-treatment-of-osteosarcoma